HireQuest, Inc. Declares Quarterly Dividend

GOOSE CREEK, SC / ACCESS Newswire / August 12, 2025 / HireQuest, Inc. (Nasdaq:HQI), a national franchisor of on-demand staffing and executive search services, today announced that its Board of Directors has declared a quarterly dividend of $0.06 per share. The dividend is payable September 15, 2025, to shareholders of record at the close of […]

Playboy Reports Second Quarter 2025 Financial Results

(NasdaqGM:PLBY), Q2 Revenue of $28.1 Million, up 13% Year-over-Year;Net Loss of $7.7 Million, an Improvement of $9.0 Million;Adjusted EBITDA of $3.5 Million, an Improvement of $6.4 Million LOS ANGELES, Aug. 12, 2025 (GLOBE NEWSWIRE) — Playboy, Inc. (NASDAQ: PLBY) (the “Company” or “Playboy”), one of the most recognizable and iconic lifestyle brands in the world,

Diginex Announces MOU for US$305m Acquisition of Findings, a leading cybersecurity and compliance automation company

(NASDAQ:DGNX),(Boerse Frankfurt – Freiverkehr:I0Q.F),(Tradegate:I0Q.F), LONDON, Aug. 12, 2025 (GLOBE NEWSWIRE) — Diginex Limited (“Diginex” or the “Company”) (NASDAQ: DGNX), a leading provider of Sustainability RegTech solutions, today announced the signing of a non-binding Memorandum of Understanding (MOU) to acquire 100% of the equity interests of IDRRA Cyber Security Ltd., which operates under the trade name

Highwoods Recasts Term Loan

(NYSE:HIW), RALEIGH, N.C., Aug. 12, 2025 (GLOBE NEWSWIRE) — Highwoods Properties, Inc. (NYSE:HIW) has executed a recast of a $200 million unsecured bank term loan by extending the maturity date from May 2026 to January 2029. The term can be extended for two additional years at our option assuming no defaults have occurred. The interest

SKYX Reports Increase of 15% with Record Second Quarter 2025 Revenues of $23.1 Million Compared to $20.1 Million for First Quarter 2025 as it Continues to Grow its Market Penetration in the U.S. and Canadian Markets

(NASDAQ:SKYX), Company reports $15.7 million in cash, cash equivalents, and restricted cash, as compared to $12.3 million as of March 31, 2025. SKYX Continues to Leverage its Cash Position Through its E-Commerce Platform of 60 Websites among Other Methods Including Support from Strategic Investors and Insiders SKYX Revenues Increased for 6 Comparable Quarters from Q1

Anterix Inc. Reports First Quarter Fiscal Year 2026 Results

(NASDAQ:ATEX), WOODLAND PARK, N.J., Aug. 12, 2025 (GLOBE NEWSWIRE) — Anterix (NASDAQ: ATEX) today announced its first quarter fiscal 2026 results and filed its Form 10-Q for the three months ended June 30, 2025. The Company also issued an update on its Demonstrated Intent metric which can be found on Anterix's website at https://investors.anterix.com/events-presentations. Financial

High Roller Reports Q2 2025 Results

(NYSE MKT:ROLR), â— Q2 2025 revenue increased 20% YoY to $6.9 million, H1 2025 revenue increased 11% YoY to $13.7 million â— Significant turnaround from Q1 as strategic optimization and realignment initiatives delivered increased revenue, decreased operating costs, and positive Adjusted EBITDA of $362 thousand â— Key achievements support positive outlook for Company performance and

NEXGEL Reports Second Quarter 2025 Financial Results

(NASDAQ:NXGL),(NASDAQ:NXGLW), Second quarter 2025 revenue totaled $2.88 million, an increase of 100.3% as compared to $1.44 million for the same period year-over-year Gross Profit for the quarter was 43.6%, compared to 20.3% for the same period in 2024 Company is reiterating revenue guidance for 2025 of $13 million and to achieve positive EBITDA during the

Cytek Biosciences to Participate in Upcoming Investor Conferences

(NASDAQ:CTKB), FREMONT, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences. UBS Precision Medicine Summit in Dana Point, CAPanel discussion: New Dimensions in Proteomics and Cellular Research on Thursday, August 14, 2025, at 8:15

BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update

(NASDAQ:BRTX), MELVILLE, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financial results for the second quarter ended June 30, 2025 and provided an update on its business. “We have continued to execute well across

Scroll to Top